RecruitingNot applicable

E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

This study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in primary care clinics with regards to hypertension control outcomes.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Official eligibility criteria

Inclusion Criteria: * Adults 18 years or older * African American and/or Latinx * Uncontrolled stage 2 hypertension, BP \>/= 140/90 * Patient is following with Rush primary care provider in eligible Rush primary care clinics * Patient has a smart phone (Android or iOS) * Patient has an email Exclusion Criteria: * Organ transplant recipient * On dialysis * Patient is already participating in another remote hypertension monitoring program * Patient is not interested in participating in the program * Patient has already participated in the E3 Hypertension program or the E3 Diabetes program

Study sites (1)

IL